Recruiting studies: Hemophilia A Or B

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B R
Phase 3 · 23 location(s) · Pfizer · NCT05568719 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Hea
Phase 1 · 10 location(s) · Equilibra Bioscience LLC · NCT06349473 A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Year
Phase 3 · 30 location(s) · Sanofi · NCT07285460 Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
Phase 3 · 1 location(s) · Suzhou Alphamab Co., Ltd. · NCT07545395 SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Phase 4 · 21 location(s) · American Thrombosis and Hemostasis Network · NCT04647227 A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Phase 3 · 34 location(s) · Pfizer · NCT05611801 Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Phase 3 · 75 location(s) · Pfizer · NCT05145127 Synovial Proliferation on Routine Ultrasound: Active or Inactive?
Phase N/A · 1 location(s) · Van Creveldkliniek · NCT06809972

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.